SELLAS Life Sciences Group Inc

NASDAQ:SLS 4:00:00 PM EDT

1.77

+0.06 (+3.51%)

7:59:37 PM EDT: $1.76 -0.01 (-0.57%)

SELLAS Life Sciences Group Inc Stock, NASDAQ:SLS

Times Square Tower, 7 Times Square, New York, New York 10026

United States of America

Phone: +1.646.200.5278

Number of Employees: 16

http://www.sellaslifesciences.com

Description

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.